N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol

C92H110Cl6N24O6S — CID 157323482

IUPACN-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol
SMILESCC(=O)NCCN1CCN(c2cc(Cl)cc3[nH]ncc23)CC1(C)C.CC1(C)CN(c2cc(Cl)cc3[nH]ncc23)CCN1CCNS(C)(=O)=O.Clc1cc(N2CCc3cn[nH]c3C2)c2cn[nH]c2c1.O=C1N(c2ccccc2)CNC12CCN(c1cc(Cl)cc3[nH]ncc13)CC2.O[C@@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ncc12.O[C@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ncc12
InChIInChI=1S/C20H20ClN5O.C17H24ClN5O.C16H24ClN5O2S.C13H12ClN5.2C13H15ClN2O/c21-14-10-17-16(12-23-24-17)18(11-14)25-8-6-20(7-9-25)19(27)26(13-22-20)15-4-2-1-3-5-15;1-12(24)19-4-5-23-7-6-22(11-17(23,2)3)16-9-13(18)8-15-14(16)10-20-21-15;1-16(2)11-21(6-7-22(16)5-4-19-25(3,23)24)15-9-12(17)8-14-13(15)10-18-20-14;14-9-3-11-10(6-16-17-11)13(4-9)19-2-1-8-5-15-18-12(8)7-19;2*14-8-5-10(9-3-1-2-4-13(9)17)11-7-15-16-12(11)6-8/h1-5,10-12,22H,6-9,13H2,(H,23,24);8-10H,4-7,11H2,1-3H3,(H,19,24)(H,20,21);8-10,19H,4-7,11H2,1-3H3,(H,18,20);3-6H,1-2,7H2,(H,15,18)(H,16,17);2*5-7,9,13,17H,1-4H2,(H,15,16)/t;;;;9-,13+;9-,13-/m....11/s1
InChIKeyBELGKUXQDNDEAP-WOBZZXBGSA-N
MW1892.84 g/mol
LogP16.04
Rot. Bonds14

About N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol

N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol (PubChem CID 157323482) has the molecular formula C92H110Cl6N24O6S and a molecular weight of 1892.84 g/mol. Its IUPAC name is N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol.

Molecular Properties

Compound NameN-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol
PubChem CID157323482
Molecular FormulaC92H110Cl6N24O6S
Molecular Weight1892.84 g/mol
Exact Mass1888.69
IUPAC NameN-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol
SMILESCC(=O)NCCN1CCN(c2cc(Cl)cc3[nH]ncc23)CC1(C)C.CC1(C)CN(c2cc(Cl)cc3[nH]ncc23)CCN1CCNS(C)(=O)=O.Clc1cc(N2CCc3cn[nH]c3C2)c2cn[nH]c2c1.O=C1N(c2ccccc2)CNC12CCN(c1cc(Cl)cc3[nH]ncc13)CC2.O[C@@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ncc12.O[C@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ncc12
InChIInChI=1S/C20H20ClN5O.C17H24ClN5O.C16H24ClN5O2S.C13H12ClN5.2C13H15ClN2O/c21-14-10-17-16(12-23-24-17)18(11-14)25-8-6-20(7-9-25)19(27)26(13-22-20)15-4-2-1-3-5-15;1-12(24)19-4-5-23-7-6-22(11-17(23,2)3)16-9-13(18)8-15-14(16)10-20-21-15;1-16(2)11-21(6-7-22(16)5-4-19-25(3,23)24)15-9-12(17)8-14-13(15)10-18-20-14;14-9-3-11-10(6-16-17-11)13(4-9)19-2-1-8-5-15-18-12(8)7-19;2*14-8-5-10(9-3-1-2-4-13(9)17)11-7-15-16-12(11)6-8/h1-5,10-12,22H,6-9,13H2,(H,23,24);8-10H,4-7,11H2,1-3H3,(H,19,24)(H,20,21);8-10,19H,4-7,11H2,1-3H3,(H,18,20);3-6H,1-2,7H2,(H,15,18)(H,16,17);2*5-7,9,13,17H,1-4H2,(H,15,16)/t;;;;9-,13+;9-,13-/m....11/s1
InChIKeyBELGKUXQDNDEAP-WOBZZXBGSA-N
XLogP16.04
TPSA368.27 Ų
H-Bond Donors12
H-Bond Acceptors20
Rotatable Bonds14
Heavy Atoms129
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001892.84
LogP ≤ 516.04
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1020

Analyze N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol?
The IUPAC name of N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol (CID 157323482) is N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol.
What is the SMILES notation for N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol?
The canonical SMILES for N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol is CC(=O)NCCN1CCN(c2cc(Cl)cc3[nH]ncc23)CC1(C)C.CC1(C)CN(c2cc(Cl)cc3[nH]ncc23)CCN1CCNS(C)(=O)=O.Clc1cc(N2CCc3cn[nH]c3C2)c2cn[nH]c2c1.O=C1N(c2ccccc2)CNC12CCN(c1cc(Cl)cc3[nH]ncc13)CC2.O[C@@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ncc12.O[C@H]1CCCC[C@@H]1c1cc(Cl)cc2[nH]ncc12.
What is the InChIKey of N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol?
The InChIKey is BELGKUXQDNDEAP-WOBZZXBGSA-N. The full InChI is InChI=1S/C20H20ClN5O.C17H24ClN5O.C16H24ClN5O2S.C13H12ClN5.2C13H15ClN2O/c21-14-10-17-16(12-23-24-17)18(11-14)25-8-6-20(7-9-25)19(27)26(13-22-20)15-4-2-1-3-5-15;1-12(24)19-4-5-23-7-6-22(11-17(23,2)3)16-9-13(18)8-15-14(16)10-20-21-15;1-16(2)11-21(6-7-22(16)5-4-19-25(3,23)24)15-9-12(17)8-14-13(15)10-18-20-14;14-9-3-11-10(6-16-17-11)13(4-9)19-2-1-8-5-15-18-12(8)7-19;2*14-8-5-10(9-3-1-2-4-13(9)17)11-7-15-16-12(11)6-8/h1-5,10-12,22H,6-9,13H2,(H,23,24);8-10H,4-7,11H2,1-3H3,(H,19,24)(H,20,21);8-10,19H,4-7,11H2,1-3H3,(H,18,20);3-6H,1-2,7H2,(H,15,18)(H,16,17);2*5-7,9,13,17H,1-4H2,(H,15,16)/t;;;;9-,13+;9-,13-/m....11/s1.
What are the key properties of N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol?
N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol has a molecular weight of 1892.84 g/mol, XLogP of 16.04, 14 rotatable bonds, 12 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]acetamide;N-[2-[4-(6-chloro-1H-indazol-4-yl)-2,2-dimethylpiperazin-1-yl]ethyl]methanesulfonamide;8-(6-chloro-1H-indazol-4-yl)-3-phenyl-1,3,8-triazaspiro[4.5]decan-4-one;6-(6-chloro-1H-indazol-4-yl)-1,4,5,7-tetrahydropyrazolo[5,4-c]pyridine;cis-(1R,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol;trans-(1S,2R)-2-(6-chloro-1H-indazol-4-yl)cyclohexan-1-ol is sourced from PubChem (CID 157323482), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).